ArticleAnnals of translational medicine2020

Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria.

Sunbin Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.